152 related articles for article (PubMed ID: 25450276)
1. Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.
Jin Y; Sun Y; Shi X; Zhao J; Shi L; Yu X
J Cancer Res Ther; 2014 Nov; 10 Suppl():C160-6. PubMed ID: 25450276
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating inflammatory factors in non-small cell lung cancer: a systematic review and meta-analysis.
Liao C; Yu Z; Guo W; Liu Q; Wu Y; Li Y; Bai L
Cancer Biomark; 2014; 14(6):469-81. PubMed ID: 25335739
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of TTF-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Qian HH; Xu TS; Cai XQ; Ji TL; Guo HX
Clin Chim Acta; 2015 Dec; 451(Pt B):208-14. PubMed ID: 25661085
[TBL] [Abstract][Full Text] [Related]
4. Baseline C-reactive protein level predicts survival of early-stage lung cancer: evidence from a systematic review and meta-analysis.
Leuzzi G; Galeone C; Gisabella M; Duranti L; Taverna F; Suatoni P; Morelli D; Pastorino U
Tumori; 2016 Oct; 102(5):441-449. PubMed ID: 27292573
[TBL] [Abstract][Full Text] [Related]
5. VEGF-C in non-small cell lung cancer: meta-analysis.
Jiang H; Shao W; Zhao W
Clin Chim Acta; 2014 Jan; 427():94-9. PubMed ID: 24144865
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of NF-κB expression in non-small cell lung cancer: A meta-analysis.
Gu L; Wang Z; Zuo J; Li H; Zha L
PLoS One; 2018; 13(5):e0198223. PubMed ID: 29813121
[TBL] [Abstract][Full Text] [Related]
7. Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
Berghmans T; Dusart M; Paesmans M; Hossein-Foucher C; Buvat I; Castaigne C; Scherpereel A; Mascaux C; Moreau M; Roelandts M; Alard S; Meert AP; Patz EF; Lafitte JJ; Sculier JP;
J Thorac Oncol; 2008 Jan; 3(1):6-12. PubMed ID: 18166834
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
[TBL] [Abstract][Full Text] [Related]
9. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
Yuan Y; Xu XY; Zheng HG; Hua BJ
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Hao K; Yu L; Zhang X
Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
12. Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer.
Gagnon B; Abrahamowicz M; Xiao Y; Beauchamp ME; MacDonald N; Kasymjanova G; Kreisman H; Small D
Br J Cancer; 2010 Mar; 102(7):1113-22. PubMed ID: 20234363
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
14. High expression of Bcl-2 protein predicts favorable outcome in non-small cell lung cancer: evidence from a systematic review and meta-analysis.
Zhao XD; He YY; Gao J; Zhao C; Zhang LL; Tian JY; Chen HL
Asian Pac J Cancer Prev; 2014; 15(20):8861-9. PubMed ID: 25374220
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis.
Zhang H; Gao L; Zhang B; Zhang L; Wang C
Sci Rep; 2016 Mar; 6():22618. PubMed ID: 26939789
[TBL] [Abstract][Full Text] [Related]
16. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic and Clinicopathological Significance of IGF-1R in NSCLC: a Meta-Analysis.
Zhao J; Shi X; Wang T; Ying C; He S; Chen Y
Cell Physiol Biochem; 2017; 43(2):697-704. PubMed ID: 28946136
[TBL] [Abstract][Full Text] [Related]
18. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
19. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
Kanoh Y; Abe T; Masuda N; Akahoshi T
Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
